Details der Publikation - Guidance for clinical case management of thrombosis with thrombocytopenia syndrome (TTS) following vaccination to prevent coronavirus disease (COVID-19)

Guidance for clinical case management of thrombosis with thrombocytopenia syndrome (TTS) following vaccination to prevent coronavirus disease (COVID-19)

Thrombotic Thrombocytopenia Syndrome (TTS) has emerged as a new adverse event following immunization in individuals vaccinated with COVID-19 non-replicant adenovirus vector-based vaccines (AstraZeneca COVID-19 ChAdOx-1 vaccine and Johnson & Johnson (J&J) Janssen COVID-19 Ad26.COV2-S vaccine). TTS is a serious and life-threatening adverse event. WHO has issued this interim emergency guidance to increase awareness about TTS in the context of COVID-19 vaccination and help healthcare providers in the assessment and management of potential TTS cases. Knowledge about TTS following vaccination with a COVID-19 adenovirus vector-based vaccine is rapidly evolving. WHO will continue to monitor the situation closely for any changes that may affect this interim guidance and will update the guidance as needed..

Medienart:	E-Book

Erscheinungsjahr:	[2023]
Erschienen:	Geneva: World Health Organization ; 2023

Sprache:	Englisch

Links:	www.ncbi.nlm.nih.gov [teilw. kostenfrei]

ISBN:	978-92-4-006198-9

Themen:	COVID-19 Vaccines Guideline Thrombosis

Anmerkungen:	Includes bibliographical references. - Description based on online resource; title from PDF title page (viewed July 21, 2023)

Umfang:	1 online resource (1 PDF file (41 pages)) ; illustrations

Förderinstitution / Projekttitel:

PPN (Katalog-ID):	1854974394

Internformat


LEADER	01000nam a22002652 4500
001	1854974394
003	DE-627
005	20230809094654.0
007	cr uuu---uuuuu
008	230809s2023 xx \|\|\|\|\|o 00\| \|\|eng c
020			\|a 9789240061989 \|c electronic version \|9 978-92-4-006198-9
035			\|a (DE-627)1854974394
035			\|a (DE-599)KEP095309020
035			\|a (OCoLC)1393133335
035			\|a (NCBI)9918628669006676
035			\|a (EBP)095309020
040			\|a DE-627 \|b ger \|c DE-627 \|e rda
041			\|a eng
245	1	0	\|a Guidance for clinical case management of thrombosis with thrombocytopenia syndrome (TTS) following vaccination to prevent coronavirus disease (COVID-19)
264		1	\|a Geneva \|b World Health Organization \|c [2023]
300			\|a 1 online resource (1 PDF file (41 pages)) \|b illustrations
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a Includes bibliographical references. - Description based on online resource; title from PDF title page (viewed July 21, 2023)
520			\|a Thrombotic Thrombocytopenia Syndrome (TTS) has emerged as a new adverse event following immunization in individuals vaccinated with COVID-19 non-replicant adenovirus vector-based vaccines (AstraZeneca COVID-19 ChAdOx-1 vaccine and Johnson & Johnson (J&J) Janssen COVID-19 Ad26.COV2-S vaccine). TTS is a serious and life-threatening adverse event. WHO has issued this interim emergency guidance to increase awareness about TTS in the context of COVID-19 vaccination and help healthcare providers in the assessment and management of potential TTS cases. Knowledge about TTS following vaccination with a COVID-19 adenovirus vector-based vaccine is rapidly evolving. WHO will continue to monitor the situation closely for any changes that may affect this interim guidance and will update the guidance as needed.
650		2	\|a COVID-19 Vaccines \|x adverse effects
650		2	\|a Thrombosis \|x chemically induced
655		2	\|a Guideline
710	2		\|a World Health Organization, \|e MitwirkendeR \|4 ctb
856	4	0	\|u https://www.ncbi.nlm.nih.gov/books/NBK590574/ \|m X:NCBI \|x Verlag \|z teilw. kostenfrei
912			\|a ZDB-193-NCB
912			\|a GBV_ILN_22
912			\|a ISIL_DE-18
912			\|a SYSFLAG_1
912			\|a GBV_KXP
912			\|a GBV_ILN_22_i06404
912			\|a GBV_ILN_40
912			\|a ISIL_DE-7
912			\|a GBV_ILN_74
912			\|a ISIL_DE-354
912			\|a GBV_ILN_2003
912			\|a ISIL_DE-25
912			\|a GBV_ILN_2009
912			\|a ISIL_DE-180
912			\|a GBV_ILN_2010
912			\|a ISIL_DE-15
951			\|a BO
980			\|2 22 \|1 01 \|x 0018 \|b 4374076840 \|h h64 NCBI \|y zi06404 \|z 08-09-23
980			\|2 40 \|1 01 \|x 0007 \|b 4374074953 \|h OLR-NCB-BOOKSHELF \|y xsn \|z 08-09-23
980			\|2 74 \|1 01 \|x 0354 \|b 437407306X \|c 09 \|f E-Bibl \|d EM 0000 \|e --%%-- \|j --%%-- \|y ze \|z 08-09-23
980			\|2 2003 \|1 01 \|x DE-25 \|b 4364046205 \|c 00 \|f --%%-- \|d --%%-- \|e --%%-- \|j n \|k Elektronischer Volltext - Open Access \|y l01 \|z 09-08-23
980			\|2 2009 \|1 01 \|x DE-180 \|b 4364047945 \|c 00 \|f --%%-- \|d --%%-- \|e --%%-- \|j --%%-- \|y l01 \|z 09-08-23
980			\|2 2010 \|1 01 \|x DE-15 \|b 4364047953 \|c 00 \|f --%%-- \|d --%%-- \|e --%%-- \|j n \|k Elektronischer Volltext - Open Access \|y l01 \|z 09-08-23
981			\|2 22 \|1 01 \|x 0018 \|r https://www.ncbi.nlm.nih.gov/books/NBK590574/
981			\|2 40 \|1 01 \|x 0007 \|y Volltext, Open Access \|r https://www.ncbi.nlm.nih.gov/books/NBK590574/
981			\|2 74 \|1 01 \|x 0354 \|r https://www.ncbi.nlm.nih.gov/books/NBK590574/
981			\|2 2003 \|1 01 \|x DE-25 \|r https://www.ncbi.nlm.nih.gov/books/NBK590574/
981			\|2 2010 \|1 01 \|x DE-15 \|y Online-Zugriff \|r https://www.ncbi.nlm.nih.gov/books/NBK590574/
985			\|2 22 \|1 01 \|x 0018 \|a h64 ebook
985			\|2 74 \|1 01 \|x 0354 \|a EM 0000
995			\|2 22 \|1 01 \|x 0018 \|a h64 NCBI
995			\|2 22 \|1 01 \|x 0018 \|a h64 freie Ressource
995			\|2 40 \|1 01 \|x 0007 \|a OLR-NCB-BOOKSHELF

Guidance for clinical case management of thrombosis with thrombocytopenia syndrome (TTS) following vaccination to prevent coronavirus disease (COVID-19)

Zugang & Verfügbarkeit

Zugehörige Publikationen/Bände